RCM
GOSS icon

Riverhead Capital Management’s Gossamer Bio GOSS Stock Holding History

Riverhead Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$785K Buy
585
+467
+396% +$743K 0.03% 555
2019
Q2 		$209K Buy
118
+1
+0.9% +$1.53K 0.01% 1126
2019
Q1 		$203K Buy
+117
New +$195K 0.01% 1112

Other funds holding GOSS

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Riverhead Capital Management's GOSS Position: Q3 2019 in Review

Riverhead Capital Management increased its Gossamer Bio (GOSS) stake by 396% in Q3 2019, buying an estimated $743K and bringing the position to 585 shares worth $785K. The position accounts for 0.03% of the portfolio, ranked #555.

Riverhead Capital Management first reported a position in GOSS in Q1 2019 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold GOSS as of Q3 2019.

  • Riverhead Capital Management held 585 shares of Gossamer Bio worth $785K as of Q3 2019.
  • Riverhead Capital Management bought 467 Gossamer Bio shares in Q3 2019, an estimated $743K.
  • Gossamer Bio made up 0.03% of Riverhead Capital Management's portfolio in Q3 2019, its #555 holding.
  • Riverhead Capital Management first reported a position in Gossamer Bio in Q1 2019 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.